Structure (Image 01)
Erlotinib Tablet, Film Coated
Product Images NDC 63304-135
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Erlotinib (NDC 63304-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 02)
This appears to be a graph or chart showing the progression-free survival probability for two different treatments: chemotherapy and Exlotinib. The X-axis shows the years 2000-2010, and the Y-axis shows the percentage of patients who have not experienced progression of their disease. The number of patients at risk is also shown for each treatment. However, some of the values are unclear or incomplete, so it is difficult to provide a more detailed description.*
Figure 2 (Image 03)
Figure 3 (Image 04)
This is a table representing survival probability and the number of patients at risk, with an overall survival duration in months. The table likely compares the effectiveness of a placebo treatment with Erlotinibd treatment on patients. The table includes percentages and numbers for survival probability at different time intervals. The last row seems incomplete and it's unclear what "ow" represents.*
Figure 4 (Image 05)
Erlotinib 25 mg_30 Capsules (Image 06)
This is a description of Erlotinib Tablets which are used for treating cancer. Each film-coated tablet contains erlotinib hydrochloride equivalent to 25 mg erlotinib. The package insert should be referred to for complete prescribing information, and tablets should be stored at 20° C - 25° C (68° F - 77° F). Manufactured by Sun Pharmaceutical Industries Ltd. and Distributed by Sun Pharmaceutical Industries, Inc., these tablets come in a pack of 30 tablets. The NDC code is 63304-095-30.*
Erlotinib 100 mg_30 Capsules (Image 07)
NDC 63304-096-30 is a label for Erlotinib tablets with 100 mg strength. It contains erlotinib hydrochloride equivalent to 100 mg erlotinib. The usual dosage of the medicine is mentioned in the package insert. The tablets should be stored at a temperature between 20°C-25°C (68°F - 77°F). This medicine is manufactured by Sun Pharmaceutical Industries Ltd. and distributed by Sun Pharmaceutical Industries, Inc. However, no information is available regarding its usage and benefits.*
Erlotinib 150 mg_30 Capsules (Image 08)
This is a label of Erlotinib Tablets, a prescription drug that comes in a bottle of 30 tablets, each containing 150 mg of erlotinib hydrochloride. The usual dosage is provided in the package insert. This drug is manufactured by Top Laver and distributed by Sun Pharmaceutical Industries, with addresses in New Jersey and Gujarat, India. It should be stored at controlled room temperature between 20-25°C (68-77°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
